Načítá se...
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDA) is an aggressive malignancy that carries a poor prognosis with a 5-year survival on the order of 6%(1); new and innovative treatments are needed. Several factors underlie its aggressive nature and resistance to treatment: the genetic framework, early metastasis...
Uloženo v:
| Vydáno v: | Hematol Oncol Clin North Am |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697145/ https://ncbi.nlm.nih.gov/pubmed/26226899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2015.04.003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|